Journal profile · GENETICS & HEREDITY
Human Genetics and Genomics Advances
ISSN 2666-2477 · Elsevier · United States
Human Genetics and Genomics Advances: CAS Zone 2 · Biology (2025 upgraded edition); impact factor 3.1 (journal website); fully open access; APC about USD 2,640; median 136 days to acceptance (103 articles, last 24 months); 135 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Human Genetics and Genomics Advances is published by Elsevier and is in Zone 2 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Genomics and Rare Diseases, Genetic Associations and Epidemiology and BRCA gene mutations in cancer, together about 37.4% of its articles. Its main subfields are Genetics and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Human Genetics and Genomics Advances is an open-access journal publishing across the complete spectrum of human genetic and genomic research. Its mission is to build the human genetics and genomics knowledge base. HGG Advances is a home for human genetics and genomics research characterized by high standards of scientific rigor, validity, and reproducibility.HGG Advances is an important addition to the American Society of Human Genetics family of journals. It offers researchers a home for a wide variety of research findings and formats and is committed to prompt dissemination of results through timely peer review, continuous online publication, and innovation in responding to the human genetics and genomics community's needs as the field evolves.
From the journal's Aims & Scope
Research area (LetPub): GENETICS & HEREDITY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology15.8%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology15.5%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology6.2%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology6.2%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology5.1%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology4.9%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.6%
- Congenital heart defects researchBiochemistry, Genetics and Molecular Biology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Genetics & Heredity | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.1Publisher website ·
- CiteScore 2026-06
- 6.1LetPub ·
- CiteScore (publisher)
- 6.1Publisher website ·
- SJR 2026-06
- 1.76LetPub ·
- SNIP 2026-06
- 1.14LetPub ·
- h-index
- 27OpenAlex ·
- i10-index
- 126OpenAlex ·
- 2-year mean citedness
- 2.22OpenAlex ·
- Self-citation rate
- 6.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 133LetPub ·
Articles by year OpenAlex count · 545 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 98 | 98 | 27 |
| 2025 | 135 | 135 | 201 |
| 2024 | 109 | 109 | 530 |
| 2023 | 67 | 67 | 637 |
| 2022 | 70 | 70 | 1,112 |
| 2021 | 55 | 55 | 1,368 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
136 daysMedian, submission to acceptance · P25–P75 109 days – 168 days
- Acceptance to online
- median 4 days (103 articles)
- Submission to online
- median 140 days
- Sample
- 103 articles with submission and acceptance dates (292 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Submission to acceptance
- 138 daysPublisher website ·
- Submission to publication (journal-reported)
- about 23 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,640 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 3,300 / EUR 3,060 / GBP 2,640 / JPY 409,300 | — | — | |
| LetPub | USD 3,000 | Yes | — | |
| Publisher website | USD 3,300 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 3,300 (excluding taxes).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United States
- Language
- English
- ISSN
- 2666-2477
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about Human Genetics and Genomics Advances
What CAS zone is Human Genetics and Genomics Advances in?
In the 2025 upgraded edition of the CAS Journal Ranking, Human Genetics and Genomics Advances is in Zone 2 of Biology, and in Zone 3 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Human Genetics and Genomics Advances?
The journal's website gives an impact factor of 3.1; this is the journal's own figure, as LetPub lists none for it; CiteScore 6.1, h-index 27.
How long does peer review take at Human Genetics and Genomics Advances?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 136 days (interquartile range 109–168 days); authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Human Genetics and Genomics Advances?
According to LetPub and DOAJ records, Human Genetics and Genomics Advances is indexed in ESCI, Scopus and DOAJ.
Is Human Genetics and Genomics Advances open access, and what is the APC?
Human Genetics and Genomics Advances is a fully open-access journal. APC about USD 2,640.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .